Physician profile
Bryan W Kluck
NPI 1659486959
$60,281.56
in general payments reported to CMS, 2019-2025
38 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $6,570 · 2021: $3,331 · 2022: $587 · 2023: $7,846 · 2024: $1,229 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,542 · Food and Beverage: $3,064 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,541.67 |
| Food and Beverage | $3,064.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $23,550.01 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $13,858.26 | 2019-2024 | Watchman Access System, Jetstream Sc, Varithena Administration Pack |
| Chiesi USA, INC. | $5,524.83 | 2019-2021 | |
| Abiomed | $4,658.67 | 2019-2022 | |
| Angiodynamics, INC. | $3,541.67 | 2023 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $3,024.87 | 2021-2024 | Venaseal, Linq II |
| Portola Pharmaceuticals, LLC | $2,486.54 | 2019 | |
| Biotronik INC. | $506.05 | 2019-2025 | Orsiro Mission, Nhancer Rx, Recross |
| Tactile Systems Technology INC | $412.46 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Novartis Pharmaceuticals Corporation | $325.92 | 2019-2025 | |
| Abbott Laboratories | $315.41 | 2019-2025 | Xience Skypoint, Diamondback Coronary, Jeti Peripheral Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $234.90 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $223.99 | 2020-2024 | Camzyos |
| Medtronic Vascular, INC. | $185.90 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.42 | 2023-2025 | Jardiance |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $125.27 | 2022-2023 | Venovo |
| Astrazeneca Pharmaceuticals LP | $121.03 | 2023-2024 | Farxiga |
| Cardiovascular Systems INC. | $117.65 | 2019 | |
| Esperion Therapeutics, INC. | $113.18 | 2024-2025 | Nexletol |
| Amgen INC. | $112.49 | 2023-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $98.99 | 2024 | Arcalyst |
| Philips North America LLC | $81.24 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $75.68 | 2023-2025 | Opsumit, Opsynvi, Uptravi |
| Edwards Lifesciences Corporation | $73.03 | 2019-2021 | |
| Pfizer INC. | $71.21 | 2023-2024 | |
| Novo Nordisk INC | $58.00 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Reflow Medical INC | $37.35 | 2024 | |
| Infobionic, INC | $26.50 | 2023 | Mome Kardia |
| Merck Sharp & Dohme LLC | $22.34 | 2025 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $20.39 | 2024 | Livalo |
| Inari Medical, INC. | $20.38 | 2020 | |
| Glaxosmithkline, LLC. | $19.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.71 | 2025 | |
| Daiichi Sankyo INC. | $16.99 | 2023 | Injectafer |
| Cardiva Medical, INC. | $16.83 | 2022 | |
| Braemar Manufacturing, LLC | $16.15 | 2019 | |
| Cashflow Solutions, LLC | $15.15 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Kluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.